MedPath

Early Non Invasive Ventilation in Immuno-compromized Patients With Acute Respiratory Failure.

Not Applicable
Completed
Conditions
Adult
Acute Respiratory Failure Admitted in ICU
Immuno Compromized
Interventions
Procedure: Oxygen therapy only
Procedure: Early non invasive ventilation
Registration Number
NCT01915719
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

Assess the superiority of early non invasive ventilation in comparison to Oxygen therapy only, for immuno-compromized patients with acute respiratory failure

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
374
Inclusion Criteria
  • Age over 18 years old
  • ICU admission
  • Acute respiratory failure defined by (PaO2<60 mmHg at room air) or (polypnea >30/min or dyspnea at rest) or respiratory distress. Since less than 72 hours.
  • Immuno compromized patient defined by solid tumor (treated since less than 5 years) or haematological malignancy (treated since less than 5 years) or Solid organ transplantation or Stem cell transplantation or Immunosuppressive treatment (steroid > 1mg/kg/d or >1 month or other immunosuppressive treatment >1 month)
Exclusion Criteria
  • Hypercapnia >50 mmHg or increased of hypercapnia >10 mmHg under Oxygen treatment
  • Need of immediate mechanical ventilation
  • Obvious cardiogenic oedema
  • Vasopressor use >0.03 µg/kg/min
  • Glasgow Score <13
  • End of life decision
  • Acute myocardial infarction
  • Patient refusal
  • Pregnancy
  • No national health insurance

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Oxygen therapy onlyOxygen therapy onlyOxygen therapy only
Early non invasive ventilationEarly non invasive ventilationEarly non invasive ventilation
Primary Outcome Measures
NameTimeMethod
Day 28 MortalityDay 28
Secondary Outcome Measures
NameTimeMethod
Nosocomial infectionday 28
Length of stay in ICUDay 28
Needs of mechanical ventilationDay 28
SOFA ScoreHour 72
performance status (OMS scale ranging from 0-perfect status- to 4-moribund)6 Months

Trial Locations

Locations (1)

APHP, Hôpital Saint Louis

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath